Discussions

Tumor neoantigen is a new direction of tumor treatment, and it is a truly personalized treatment plan. During the growth of cancer cells, a series of DNA-specific mutations are often accompanied by a series of DNA-specific mutations, stimulating cancer cells to develop drug resistance or rapid growth, and this specific mutation is different in tumor cells of different patients, making traditional tumor drugs less effective. Tumor neoantigens are protein or polypeptide fragments produced by tumor cell-specific mutations, which have individual differences and immune tolerance, and are ideal targets for drugs and treatments. Tumor neoantigen drugs represent a new direction for tumor treatment, and the application of relevant drugs and the implicit approval of clinical trials mark that personalized precision therapy has entered the clinical stage.

Visit US:https://www.alfaoncology.com/neoantigens/services/new-antigenic-peptide-ind-service.html